These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25102981)

  • 1. Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease.
    Ahn SB; Jang K; Jun DW; Lee BH; Shin KJ
    Dig Dis Sci; 2014 Dec; 59(12):2975-82. PubMed ID: 25102981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal Niemann-Pick C1-like 1 expression was negatively correlated with liver X receptor expression in nonalcoholic fatty liver disease.
    Ahn SB; Jun DW; Jang K; Lee BH; Shin KJ
    Korean J Intern Med; 2019 Jul; 34(4):777-784. PubMed ID: 29466845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C.
    Lima-Cabello E; García-Mediavilla MV; Miquilena-Colina ME; Vargas-Castrillón J; Lozano-Rodríguez T; Fernández-Bermejo M; Olcoz JL; González-Gallego J; García-Monzón C; Sánchez-Campos S
    Clin Sci (Lond); 2011 Mar; 120(6):239-50. PubMed ID: 20929443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptors bridge hepatic lipid metabolism and inflammation.
    Liu Y; Qiu DK; Ma X
    J Dig Dis; 2012 Feb; 13(2):69-74. PubMed ID: 22257474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease.
    Li X; Wang Z; Klaunig JE
    Toxicology; 2018 Dec; 410():199-213. PubMed ID: 30120929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease.
    Nakamuta M; Fujino T; Yada R; Yada M; Yasutake K; Yoshimoto T; Harada N; Higuchi N; Kato M; Kohjima M; Taketomi A; Maehara Y; Nakashima M; Kotoh K; Enjoji M
    Int J Mol Med; 2009 May; 23(5):603-8. PubMed ID: 19360318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LXR-α antagonist meso-dihydroguaiaretic acid attenuates high-fat diet-induced nonalcoholic fatty liver.
    Sim WC; Park S; Lee KY; Je YT; Yin HQ; Choi YJ; Sung SH; Park SJ; Park HJ; Shin KJ; Lee BH
    Biochem Pharmacol; 2014 Aug; 90(4):414-24. PubMed ID: 24955981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease.
    Aguilar-Olivos NE; Carrillo-Córdova D; Oria-Hernández J; Sánchez-Valle V; Ponciano-Rodríguez G; Ramírez-Jaramillo M; Chablé-Montero F; Chávez-Tapia NC; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2015; 14(4):487-93. PubMed ID: 26019035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
    Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
    Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression.
    Pawar A; Botolin D; Mangelsdorf DJ; Jump DB
    J Biol Chem; 2003 Oct; 278(42):40736-43. PubMed ID: 12917410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin improves hepatic steatosis via CD36 pathway.
    Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
    J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model.
    Ipsen DH; Skat-Rørdam J; Tsamouri MM; Latta M; Lykkesfeldt J; Tveden-Nyborg P
    Mol Genet Genomics; 2019 Jun; 294(3):649-661. PubMed ID: 30759275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
    Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
    Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease.
    Afonso MB; Rodrigues PM; Mateus-Pinheiro M; Simão AL; Gaspar MM; Majdi A; Arretxe E; Alonso C; Santos-Laso A; Jimenez-Agüero R; Eizaguirre E; Bujanda L; Pareja MJ; Banales JM; Ratziu V; Gautheron J; Castro RE; Rodrigues CMP
    Gut; 2021 Dec; 70(12):2359-2372. PubMed ID: 33361348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hexane Fraction of cyperus rotundus Prevents Non-Alcoholic Fatty Liver Disease Through the Inhibition of Liver X Receptor α-Mediated Activation of Sterol Regulatory Element Binding Protein-1c.
    Oh GS; Yoon J; Lee GG; Kwak JH; Kim SW
    Am J Chin Med; 2015; 43(3):477-94. PubMed ID: 25967664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRMT3 regulates hepatic lipogenesis through direct interaction with LXRα.
    Kim DI; Park MJ; Lim SK; Park JI; Yoon KC; Han HJ; Gustafsson JÅ; Lim JH; Park SH
    Diabetes; 2015 Jan; 64(1):60-71. PubMed ID: 25187371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis.
    Huang P; Kaluba B; Jiang XL; Chang S; Tang XF; Mao LF; Zhang ZP; Huang FZ
    Biomed Res Int; 2018; 2018():8071093. PubMed ID: 29670908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
    Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
    Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD
    Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.